Table 2.
Tests | Result | Grade | Male | Female | ||||||
---|---|---|---|---|---|---|---|---|---|---|
G1 | G2 | G3 | G4 | G1 | G2 | G3 | G4 | |||
GLU | – | 0 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
BIL | – | 0 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
KET | – | 0 | 2 | 2 | 2 | 0 | 3 | 3 | 3 | 2 |
+/− | 1 | 1 | 1 | 1 | 3 | 0 | 0 | 0 | 1 | |
SG | ≤1.005 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
1.010 | 1 | 0 | 0 | 1 | 0 | 2 | 1 | 1 | 0 | |
1.015 | 2 | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 1 | |
1.020 | 3 | 0 | 2 | 1 | 0 | 0 | 1 | 0 | 1 | |
1.025 | 4 | 3 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | |
≥1.030 | 5 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | |
pH | 6.5 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
7.0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | |
7.5 | 2 | 1 | 0 | 1 | 0 | 3 | 3 | 3 | 2 | |
8.0 | 3 | 1 | 0 | 2 | 1 | 0 | 0 | 0 | 1 | |
8.5 | 4 | 0 | 1 | 0 | 0 | 3 | 3 | 3 | 1 | |
PRO | – | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2 |
+/− | 1 | 0 | 0 | 1 | 1 | 3 | 3 | 3 | 3 | |
1+ | 2 | 3 | 3 | 1 | 2 | 3 | 3 | 3 | 3 | |
URO | 0.2 | 0 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 3 |
NIT | – | 0 | 3 | 3 | 3 | 3 | 0 | 0 | 1 | 0 |
BLO | – | 0 | 3 | 3 | 3 | 3 | 0 | 1 | 0 | 0 |
LEU | – | 0 | 2 | 1 | 1 | 0 | 3 | 3 | 3 | 3 |
+/− | 1 | 0 | 2 | 1 | 1 | 3 | 3 | 3 | 3 | |
1+ | 2 | 1 | 0 | 1 | 2 | 3 | 3 | 3 | 3 | |
Clarity | – | 0 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Color-Yellow | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
G1: negative control; G2: 500 mg/kg OE treated group; G3: 1000 mg/kg OE treated group; G4: 2000 mg/kg OE treated group. GLU: glucose (mg/dL); BIL: bilirubin (mg/dL); KET: ketone bodies (mg/dL); SG: specific gravity; PRO: protein (mg/dL); URO: urobilinogen (mg/dL); NIT: nitrites (mg/dL); BLO: Occult blood: LEU: leukocytes (Leu/dL). Results were analyzed using the non-parametric Kruskal-Wallis test but there were no significance differences among the groups